MENU
TNXP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Tonix Pharmaceuticals Holding (TNXP) Earnings Date & Reports

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering... Show more

A.I. Advisor
published Earnings

TNXP is expected to report earnings to fall 20.21% to -307 cents per share on November 10

Tonix Pharmaceuticals Holding TNXP Stock Earnings Reports
Q3'25
Est.
$-3.08
Q2'25
Beat
by $2.97
Q1'25
Beat
by $22.84
Q4'24
Missed
by $5.86
Q3'24
Beat
by $2.70
The last earnings report on August 11 showed earnings per share of -385 cents, beating the estimate of -682 cents. With 674.41K shares outstanding, the current market capitalization sits at 259.73M.
View a ticker or compare two or three
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TNXP showed earnings on August 11, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a company which engages in developing and manufacturing pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
26 Main Street
Phone
+1 862 799-8599
Employees
103
Web
https://www.tonixpharma.com